Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

被引:59
|
作者
Redfors, Bjorn [1 ,2 ,3 ]
Furer, Ariel [1 ,4 ,5 ]
Selker, Harry P. [6 ]
Thiele, Holger [7 ,8 ]
Patel, Manesh R. [9 ]
Chen, Shmuel [1 ,2 ]
Udelson, James E. [10 ]
Ohman, E. Magnus [9 ]
Eitel, Ingo [11 ,12 ]
Granger, Christopher B. [9 ]
Maehara, Akiko [1 ,2 ]
Kirtane, Ajay J. [1 ,2 ]
Genereux, Philippe [1 ,13 ,14 ]
Jenkins, Paul L. [15 ]
Ben-Yehuda, Ori [1 ,2 ]
Stone, Gregg W. [1 ,16 ]
机构
[1] Cardiovasc Res Fdn, Clin Trials Ctr, New York, NY USA
[2] Columbia Univ, Med Ctr, Dept Cardiol, NewYork Presbyterian Hosp, New York, NY USA
[3] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden
[4] Israel Def Forces, Med Corps, Tel Hashomer, Israel
[5] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mil Med, Jerusalem, Israel
[6] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA
[7] Univ Leipzig, Heart Ctr Leipzig, Leipzig, Germany
[8] Leipzig Heart Inst, Leipzig, Germany
[9] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA
[10] Tufts Med Ctr, Div Cardiol, Boston, MA 02111 USA
[11] Univ Heart Ctr Lubeck, Univ Hosp Schleswig Holstein, Med Clin Cardiol Angiol Intens Care Med 2, Lubeck, Germany
[12] German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Lubeck, Lubeck, Germany
[13] Morristown Med Ctr, Gagnon Cardiovasc Inst, Morristown, NJ USA
[14] Hop Sacre Coeur Montreal, Montreal, PQ, Canada
[15] Mary Imogene Bassett Hosp, Cooperstown, NY USA
[16] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA
基金
美国国家卫生研究院;
关键词
infarct size; percutaneous coronary intervention (PCI); smoking; ST-segment elevation myocardial infarction (STEMI); ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RECEIVING THROMBOLYTIC THERAPY; BOLUS ABCIXIMAB APPLICATION; SMOKERS PARADOX; CIGARETTE-SMOKING; POOLED ANALYSIS; GUSTO-I; SIZE; TRIAL;
D O I
10.1016/j.jacc.2020.02.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Smoking is a well-established risk factor for ST-segment elevation myocardial infarction (STEMI); however, once STEMI occurs, smoking has been associated with favorable short-term outcomes, an observation termed the "smoker's paradox." It has been postulated that smoking might exert protective effects that could reduce infarct size, a strong independent predictor of worse outcomes after STEMI. OBJECTIVES The purpose of this study was to determine the relationship among smoking, infarct size, microvascular obstruction (MVO), and adverse outcomes after STEMI. METHODS Individual patient-data were pooled from 10 randomized trials of patients with STEMI undergoing primary percutaneous coronary intervention. Infarct size was assessed at median 4 days by either cardiac magnetic resonance imaging or technetium-99m sestamibi single-photon emission computed tomography. Multivariable analysis was used to assess the relationship between smoking, infarct size, and the 1-year rates of death or heart failure (HF) hospitalization and reinfarction. RESULTS Among 2,564 patients with STEMI, 1,093 (42.6%) were recent smokers. Smokers were 10 years younger and had fewer comorbidities. Infarct size was similar in smokers and nonsmokers (adjusted difference: 0.0%; 95% confidence interval [CI]: -3.3% to 3.3%; p = 0.99). Nor was the extent of MVO different between smokers and nonsmokers. Smokers had lower crude 1-year rates of all-cause death (1.0% vs. 2.9%; p < 0.001) and death or HF hospitalization (3.3% vs. 5.1%; p = 0.009) with similar rates of reinfarction. After adjustment for age and other risk factors, smokers had a similar 1-year risk of death (adjusted hazard ratio [adjHR]: 0.92; 95% CI: 0.46 to 1.84) and higher risks of death or HF hospitalization (adjHR: 1.49; 95% CI: 1.09 to 2.02) as well as reinfarction (adjHR: 1.97; 95% CI: 1.17 to 3.33). CONCLUSIONS In the present large-scale individual patient-data pooled analysis, recent smoking was unrelated to infarct size or MVO, but was associated with a worse prognosis after primary PCI in STEMI. The smoker's paradox may be explained by the younger age and fewer cardiovascular risk factors in smokers compared with nonsmokers. (C) 2020 by the American College of Cardiology Foundation.
引用
收藏
页码:1743 / 1754
页数:12
相关论文
共 50 条
  • [1] Bundle branch blocks and outcomes in STEMI patients treated with primary PCI
    Har, B.
    Galbraith, P. D.
    Southern, D.
    Zhang, M.
    Bizios, A.
    Knudtson, M. L.
    EUROPEAN HEART JOURNAL, 2014, 35 : 971 - 971
  • [2] Outcomes of COVID-19 patients with STEMI undergoing primary PCI
    Kleczynski, P.
    Niewiara, L.
    Kulbat, A.
    Kaczynski, M.
    Pawlowski, T.
    Socha, S.
    Rakowski, T.
    Gil, R.
    Bartus, S.
    Legutko, J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1250 - 1250
  • [3] In-hospital outcomes of STEMI patients on warfarin undergoing primary PCI
    Marbach, Jeffrey A.
    Almufleh, Aws
    Bernick, Jordan
    Blondeau, Melissa
    Osborne, Christina
    Russo, Juan
    Hibbert, Benjamin
    Froeschl, Michael
    Labinaz, Marino
    Glover, Christopher
    Dick, Alexander
    So, Derek
    Chong, Aun-Yeong
    Le May, Michel
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (01) : 41 - 47
  • [4] Effect of prehospital treatment in STEMI patients undergoing primary PCI
    Fabris, Enrico
    Menzio, Sara
    Gregorio, Caterina
    Pezzato, Andrea
    Stolfo, Davide
    Aleksova, Aneta
    Vitrella, Giancarlo
    Rakar, Serena
    Perkan, Andrea
    Van't Hof, Arnoud W. J.
    Sinagra, Gianfranco
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2022, 99 (05) : 1500 - 1508
  • [5] Update on primary PCI for patients with STEMI
    Thomas, Michael P.
    Bates, Eric R.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2017, 27 (02) : 95 - 102
  • [6] EFFECT OF TIME OF DAY ON OUTCOMES OF PCI FOR STEMI
    Karnik, A.
    Lee, J.
    Choi, E.
    Aguilar, J.
    Li, S.
    Kumar, V.
    Conley, S.
    Niles, N. W., II
    Andrus, B. W.
    DeVries, J. T.
    CARDIOLOGY, 2018, 140 : 371 - 371
  • [7] Primary PCI in the very elderly: A study of outcomes in patients aged > 85 years with STEMI
    Jariwala, P.
    Jadhav, Kartik
    EUROPEAN HEART JOURNAL, 2022, 43
  • [8] The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI
    Kaymaz, Cihangir
    Keles, Nursen
    Ozdemir, Nihal
    Tanboga, Ibrahim Halil
    Demircan, Hacer C. T.
    Can, Mehmet M.
    Koca, Fatih
    Izgi, Ibrahim Akin
    Ozkan, Alper
    Turkmen, Muhsin
    Kirma, Cevat
    Esen, Ali M.
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2015, 15 (11): : 899 - 906
  • [9] Effect of pre-hospital treatment for STEMI patients undergoing primary PCI
    Fabris, Enrico
    Menzio, Sara
    Gregorio, Caterina
    Pezzato, Andrea
    Stolfo, Davide
    Aleksova, Aneta
    Vitrella, Giancarlo
    Rakar, Serena
    Perkan, Andrea
    Van't Hof, Arnoud W. J.
    Sinagra, Gianfranco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [10] Effect of pre-hospital treatment for STEMI patients undergoing primary PCI
    Fabris, Enrico
    Menzio, Sara
    Gregorio, Caterina
    Pezzato, Andrea
    Stolfo, Davide
    Aleksova, Aneta
    Vitrella, Giancarlo
    Rakar, Serena
    Perkan, Andrea
    Van't Hof, Arnoud W. J.
    Sinagra, Gianfranco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)